Les patients atteints de polyarthrite rhumatoïde profitent d’un traitement qui a fait ses preuves

SPECIAL REPORT

Rheumatoid Arthritis

EULAR 2021

SPECIAL REPORT

Further Publications Dermatology

Gonflement à répétition de la peau, des muqueuses et des organes internes

Rheumatoid Arthritis

Patienten mit rheumatoider Arthritis profitieren von bewährter Therapie

Dieser Artikel wurde von Bristol-Myers Squibb SA unterstützt

Autoimmune Disease

[Autoimmune diseases in the context of pandemic COVID-19]

Rev Med Suisse.

Horisberger A, Moi L, Ribi C, Comte D

doi: undefined.

Rheumatoid Arthritis

Prevalence of depression and anxiety in rheumatoid arthritis patients and their associations with serum vitamin D level

Clin Rheumatol.

Pu D, Luo J, Wang Y, Ju B, Lv X, Fan P, He L

doi: 10.1007/s10067-017-3874-4.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

[Rheumatology and COVID-19]

Rev Med Suisse.

Dumusc A, Dan D

doi: undefined.

Psoriatic Arthritis

Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries

Ann Rheum Dis.

Gorlier C, Orbai AM, Puyraimond-Zemmour D, Coates LC, Kiltz U, Leung YY, Palominos P, Cañete JD, Scrivo R, Balanescu A, Dernis E, Tälli S, Ruyssen-Witrand A, Soubrier M, Aydin SZ, Eder L, Gaydukova I, Lubrano E, Kalyoncu U, Richette P, Husni ME, de Wit M, Smolen JS, Gossec L

doi: 10.1136/annrheumdis-2018-214140.

Rheumatoid Arthritis

Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis

RMD Open.

Emery P, Blanco R, Maldonado Cocco J, Chen YC, Gaich CL, DeLozier AM, de Bono S, Liu J, Rooney T, Chang CH, Dougados M

doi: 10.1136/rmdopen-2016-000410.

Rheumatoid Arthritis

Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON).

Ann Rheum Dis.

Smolen JS, Kremer JM, Gaich CL, DeLozier AM, Schlichting DE, Xie L, Stoykov I, Rooney T, Bird P, Sánchez Bursón JM, Genovese MC, Combe B

doi: 10.1136/

Related content

EULAR 2021

Gonflement à répétition de la peau, des muqueuses et des organes internes

Patienten mit rheumatoider Arthritis profitieren von bewährter Therapie

[Autoimmune diseases in the context of pandemic COVID-19]

Prevalence of depression and anxiety in rheumatoid arthritis patients and their associations with serum vitamin D level

[Rheumatology and COVID-19]

Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries

Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis

Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON).